Development and external validation of a clinical prediction model to estimate unfavorable graft outcome in patients with severe kidney transplant rejection eligible for treatment with alemtuzumab
- DOI
- 10.1016/j.imbio.2026.153261
- Published
- 2026-11
- Container
- Immunobiology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.imbio.2026.153261,
title = {Development and external validation of a clinical prediction model to estimate unfavorable graft outcome in patients with severe kidney transplant rejection eligible for treatment with alemtuzumab},
author = {Lukas K. van Vugt and Dennis A.J. van den Broek and Pedro Miranda Afonso and Danny van der Helm and Alvaro Assis de Souza and Brenda C.M. de Winter and Marlies E.J. Reinders and Marian C. Clahsen-van Groningen and Jesper Kers and Aiko P.J. de Vries and Dennis A. Hesselink},
year = {2026},
journal = {Immunobiology},
doi = {10.1016/j.imbio.2026.153261},
url = {https://doi.org/10.1016/j.imbio.2026.153261}
}RIS
TY - JOUR TI - Development and external validation of a clinical prediction model to estimate unfavorable graft outcome in patients with severe kidney transplant rejection eligible for treatment with alemtuzumab AU - Lukas K. van Vugt AU - Dennis A.J. van den Broek AU - Pedro Miranda Afonso AU - Danny van der Helm AU - Alvaro Assis de Souza AU - Brenda C.M. de Winter AU - Marlies E.J. Reinders AU - Marian C. Clahsen-van Groningen AU - Jesper Kers AU - Aiko P.J. de Vries AU - Dennis A. Hesselink PY - 2026 JO - Immunobiology DO - 10.1016/j.imbio.2026.153261 UR - https://doi.org/10.1016/j.imbio.2026.153261 ER -
APA
Vugt, L. K. V., Broek, D. A. V. D., Afonso, P. M., Helm, D. V. D., Souza, A. A. D., Winter, B. C. D., Reinders, M. E., Groningen, M. C. C., Kers, J., Vries, A. P. D., & Hesselink, D. A. (2026). Development and external validation of a clinical prediction model to estimate unfavorable graft outcome in patients with severe kidney transplant rejection eligible for treatment with alemtuzumab. Immunobiology. https://doi.org/10.1016/j.imbio.2026.153261
Source records
- crossref · retrieved 2026-11-10T20:14:27.765Z